ConductScience.org, home

Paper427798

Activity of a novel anthracenedione, 1,4-dihydroxy-5,8-bis(((2-[(2-hydroxyethyl)amino]ethyl)amino])-9,10-anthracenedione dihydrochloride, against experimental tumors in mice.

Wallace RE and 3 others. Cancer Res, 1979. Cited by 196 papers, by iCite.

Cite this record

ConductScience Library. Activity of a novel anthracenedione, 1,4-dihydroxy-5,8-bis(((2-[(2-hydroxyethyl)amino]ethyl)amino])-9,10-anthracenedione dihydrochloride, against experimental tumors in mice. Papers, record 427798. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/427798

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Activity of a novel anthracenedione, 1,4-dihydroxy-5,8-bis(((2-[(2-hydroxyethyl)amino]ethyl)amino])-9,10-anthracenedione dihydrochloride, against experimental tumors in mice.
PubMed
Journal
Cancer Res
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
196
iCite
Relative citation ratio, by iCite
7.72
iCite
Revised in PubMed
2003-11-14
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wallace RER E
2Murdock KCK C
3Angier RBR B
4Durr FEF E

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AnthracenesMajor topic
Antineoplastic AgentsMajor topic
Neoplasms, ExperimentalMajor topic
Animals
Colonic Neoplasms
Injections
Leukemia, Experimental
Lung Neoplasms
Male
Melanoma
Mice
Mice, Inbred Strains

Source PubMed

Download CSV of topics

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 196 citations.

PMIDTitleJournalYearIn PapersSource
34671088Genetic landscape of T cells identifies synthetic lethality for T-ALL.Commun Biol2021https://conductscience.org/library/papers/34671088PubMed
25295084Salvage therapy with mitoxantrone, etoposide, bleomycin and dexamethasone for refractory or relapsed aggressive non-Hodgkin's lymphoma patients with a poor performance status or comorbidity.Oncol Lett2014https://conductscience.org/library/papers/25295084PubMed
17483512Pixantrone can be activated by formaldehyde to generate a potent DNA adduct forming agent.Nucleic Acids Res2007https://conductscience.org/library/papers/17483512PubMed
10091119Major versus minor groove DNA binding of a bisarginylporphyrin hybrid molecule: a molecular mechanics investigation.J Comput Aided Mol Des1999https://conductscience.org/library/papers/10091119PubMed
7460190Phase I clinical trial f mitoxantrone: a new anthracenedione anticancer drug.Cancer Chemother Pharmacol1980https://conductscience.org/library/papers/7460190PubMed
7105379Antitumor activity of mitoxantrone against murine experimental tumors: comparative analysis against various antitumor antibiotics.Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/7105379PubMed
7094196Pharmacology of mitoxantrone in cancer patients.Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/7094196PubMed
6690066Mitoxantrone: an active new agent in the treatment of advanced breast cancer.Cancer Chemother Pharmacol1984https://conductscience.org/library/papers/6690066PubMed
6687221Correlation of the structure of amino-substituted anthraquinones to cytotoxicity in cultured Chinese hamster cells.Invest New Drugs1983https://conductscience.org/library/papers/6687221PubMed
6678863Comparative cytotoxicity of adriamycin, mitoxantrone and bisantrene as measured by a human tumor cloning system.Invest New Drugs1983https://conductscience.org/library/papers/6678863PubMed
6678857Mitoxantrone hydrochloride (NSC-310739) in lymphoma. A Southwest Oncology Group study.Invest New Drugs1983https://conductscience.org/library/papers/6678857PubMed
6544900Plasma kinetics of mitoxantrone in leukemic patients.Med Oncol Tumor Pharmacother1984https://conductscience.org/library/papers/6544900PubMed
6416699Cooperative studies of systemic chemotherapy. A review of the work of the EORTC Urological Group and of the Yorkshire Urological Cancer Research Group (YUCRG).Cancer Chemother Pharmacol1983https://conductscience.org/library/papers/6416699PubMed
4019123Mitoxantrone in malignant lymphoma.Invest New Drugs1985https://conductscience.org/library/papers/4019123PubMed
4019122Mitoxantrone in refractory acute leukemia in children: a phase I study.Invest New Drugs1985https://conductscience.org/library/papers/4019122PubMed
3894277A randomized trial of doxorubicin, mitoxantrone and bisantrene in advanced breast cancer (a South West Oncology Group Study).Invest New Drugs1985https://conductscience.org/library/papers/3894277PubMed
3860490Mitoxantrone in the treatment of relapsed and refractory acute leukemia.Invest New Drugs1985https://conductscience.org/library/papers/3860490PubMed
3733373Investigation of the interaction of cardiotoxic anticancer agents using the fetal mouse heart organ culture system.Invest New Drugs1986https://conductscience.org/library/papers/3733373PubMed
3700041A phase II study of dihydroxyanthracenedione (DHAD, mitoxantrone, NSC 301739) in advanced malignant melanoma.Invest New Drugs1986https://conductscience.org/library/papers/3700041PubMed
3700039Novantrone for childhood malignant solid tumors. A pediatric oncology group phase II study.Invest New Drugs1986https://conductscience.org/library/papers/3700039PubMed

See all 31 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/427798

GET https://conductscience.org/api/papers/v1/427798/cited_by?page=2